Azulfidine EN-Tabs

Drug Description
font size

Azulfidine EN-tabs®
(sulfasalazine) Delayed Release Tablets, USP

Enteric-coated Tablets

DRUG DESCRIPTION

AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.

AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tablet in the stomach and reduce potential irritation of the gastric mucosa.

Therapeutic Classification: Anti-inflammatory agent and/or immunomodulatory agent.

Chemical Designation: 5-([p-(2-pyridylsulfamoyl)phenyl]azo) salicylic acid.

Chemical Structure:

Azulfidine EN-tabs® (sulfasalazine) Structural Formula Illustration

Molecular Formula: C18H14N4O5S

Last updated on RxList: 10/30/2009

Azulfidine EN-Tabs User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Azulfidine EN-Tabs sorted by most helpful. Patient Discussions FAQs


Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:

GI Disorders

Get the latest treatment options.